This inventor holds 2 USPTO granted patents. Top assignees: Hadasit Medical Research and Development Company Ltd., Hadasit Medical Research Services and Development Company. Active years: 2000-2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 31 
Years Active: 2000-2001
Title: Morris Mosseri: Innovator in Stereotactic Radiotreatment
Introduction
Morris Mosseri is a notable inventor based in Jerusalem, Israel. He has made significant contributions to the field of medical technology, particularly in the area of stereotactic radiotreatment. With a total of 2 patents to his name, Mosseri's work focuses on innovative methods to improve patient outcomes in coronary artery treatments.
Latest Patents
Mosseri's latest patents include groundbreaking methods for the stereotactic radiotreatment and prevention of restenosis. One of his inventions involves a method and apparatus for dynamic stereotactic radiotreatment, where a stent is implanted in a coronary artery following percutaneous transluminal coronary angioplasty. This method minimizes subsequent restenosis by utilizing external irradiation of the stent with ionizing radiation, such as gamma rays. The stent's opacity to x-rays allows for precise tracking using fluoroscopy, ensuring accurate targeting of the ionizing radiation. This innovative approach synchronizes fluoroscopic imaging and irradiation with the patient's cardiac cycle, enhancing treatment efficacy.
Career Highlights
Throughout his career, Mosseri has worked with Hadasit Medical Research Services and Development Company, as well as Hadasit Medical Research and Development Company Ltd. His experience in these organizations has contributed to his expertise in medical research and development.
Collaborations
Mosseri has collaborated with various professionals in the field, including his coworker Zeev Weshler. Their joint efforts have further advanced the research and application of stereotactic radiotreatment techniques.
Conclusion
Morris Mosseri's innovative contributions to the field of medical technology, particularly in stereotactic radiotreatment, highlight his commitment to improving patient care. His patents and collaborations reflect a dedication to advancing medical practices and enhancing treatment outcomes for patients with coronary artery issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile